Exchange Traded Concepts’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.97M Sell
321,962
-27,831
-8% -$231K 0.02% 620
2025
Q4
$2.91M Buy
349,793
+17,625
+5% +$190K 0.02% 515
2025
Q3
$4.84M Buy
332,168
+36,681
+12% +$439K 0.05% 398
2025
Q2
$3.32M Sell
295,487
-16,359
-5% -$127K 0.04% 398
2025
Q1
$1.78M Buy
311,846
+120,572
+63% +$1.23M 0.03% 413
2024
Q4
$1.88M Sell
191,274
-175,704
-48% -$1.51M 0.04% 395
2024
Q3
$2.99M Buy
366,978
+209,104
+132% +$2.1M 0.07% 236
2024
Q2
$2.11M Buy
157,874
+73,152
+86% +$2.18M 0.05% 283
2024
Q1
$3.93M Buy
84,722
+72,027
+567% +$3.73M 0.1% 193
2023
Q4
$858K Buy
12,695
+2,748
+28% +$168K 0.02% 436
2023
Q3
$720K Buy
9,947
+8,115
+443% +$649K 0.02% 451
2023
Q2
$136K Buy
+1,832
New +$108K ﹤0.01% 872
2022
Q1
Sell
-1,618
Closed -$538K 1244
2021
Q4
$538K Buy
+1,618
New +$769K 0.01% 655

Other funds holding DNA